|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net (loss) income | |||||
| Net (loss) income from discontinued operations, net of tax | |||||
| Net (loss) income from continuing operations | |||||
| Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | |||||
| Depreciation, amortization and accretion | |||||
| Asset Impairment Charges | |||||
| Loss on asset disposals, net | |||||
| Interest expense from debt issuance cost amortization | |||||
| Equity-based compensation expense | |||||
| Equity in earnings of investee | |||||
| Distributions from investee | |||||
| Deferred tax expense, net | |||||
| Foreign currency losses (gains) | |||||
| Bad debt expense, net of recoveries | |||||
| Gain on litigation settlement | |||||
| Loss on sale of accounts receivable | |||||
| Changes in assets and liabilities: | |||||
| Trade accounts receivable | |||||
| Trade accounts receivable, net | |||||
| Prepaid expenses and other | |||||
| Accounts payable and accounts payable - affiliates | |||||
| Accrued payroll and other | |||||
| Income taxes payable | |||||
| Net cash provided by operating activities - continuing operations | |||||
| Net cash (used in) provided by operating activities - discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Proceeds from fixed asset disposals | |||||
| Purchases of property and equipment, excluding finance leases | |||||
| Net cash used in investing activities - continuing operations | |||||
| Net cash provided by (used in) investing activities - discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities: | |||||
| Borrowings on credit facility | |||||
| Repayments on credit facility | |||||
| Repayments on finance lease obligations | |||||
| Debt issuance cost payments | |||||
| Taxes paid related to net share settlement of equity-based compensation | |||||
| Distributions | |||||
| Net cash used in financing activities - continuing operations | |||||
| Net cash used in financing activities - discontinued operations | |||||
| Net cash used in financing activities | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Effect of exchange rates on cash | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period (includes restricted cash equivalents of $651, $551, and $551 and cash reported in assets of discontinued operations of $5,755, $4,366, and $2,858 at December 31, 2020, 2019 and 2018, respectively) | |||||
| Cash and cash equivalents, end of period (includes restricted cash equivalents of $1,051, $651, and $551 and cash reported in assets of discontinued operations of $2,334, $5,755, and $4,366 at December 31, 2021, 2020 and 2019, respectively) | |||||
| Non-cash items: | |||||
| Accounts payable and accrued payroll and other excluded from capital expenditures | |||||
| Acquisitions of finance leases included in liabilities | |||||
| Supplemental cash flow disclosures: | |||||
| Cash taxes paid | |||||
| Cash interest paid | |||||
Loading...